Literature DB >> 3134140

Migration of lymphocytes through endothelial cell monolayers: augmentation by interferon-gamma.

N Oppenheimer-Marks1, M Ziff.   

Abstract

During normal lymphocyte recirculation and in chronic inflammation, lymphocytes emigrate from blood into the perivascular tissue. The mechanism of lymphocyte migration through the endothelial cell (EC) layer of blood vessels is poorly understood. To identify factors that control lymphocyte emigration, a method has been developed to measure human peripheral blood lymphocyte migration through monolayers of human umbilical vein EC and into nitrocellulose (NC) filters located below the EC monolayer. Counts were made of lymphocytes that had migrated into the NC filter using a particle counter. T lymphocytes attached to and migrated through EC monolayers in a T-cell-number- and time-dependent fashion. Migration required viable EC since lymphocytes failed to migrate through formaldehyde-fixed EC monolayers or monolayers of dermal fibroblasts. Interferon-gamma (IFN-gamma) markedly augmented the migration in a dose- and time-dependent manner when preincubated with the EC. When T lymphocytes were pretreated with IFN-gamma, no increase in migration was observed. Finally, IFN-gamma augmented the migration of T cells prebound to the EC, indicating that the IFN-gamma-enhanced migration was not due to increased binding of T cells to the EC, but rather to an action on the EC to facilitate subsequent migration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134140     DOI: 10.1016/0008-8749(88)90324-3

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  15 in total

1.  Characterization of high endothelial-like properties of peritubular capillary endothelium during acute renal allograft rejection.

Authors:  R Renkonen; J P Turunen; J Rapola; P Häyry
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

Review 2.  The role of cytokines in the pathogenesis of rheumatoid arthritis.

Authors:  P E Lipsky; L S Davis; J J Cush; N Oppenheimer-Marks
Journal:  Springer Semin Immunopathol       Date:  1989

3.  Bone Marrow Mesenchymal Stem Cells Combat Lipopolysaccharide-Induced Sepsis in Rats via Amendment of P38-MAPK Signaling Cascade.

Authors:  Omnia S Zaki; Marwa M Safar; Afaf A Ain-Shoka; Laila A Rashed
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

4.  Influence of stromal cells on lymphocyte adhesion and migration on endothelial cells.

Authors:  Helen M McGettrick; Chris D Buckley; G Ed Rainger; Gerard B Nash
Journal:  Methods Mol Biol       Date:  2010

Review 5.  Role of endothelium in chronic inflammation.

Authors:  M Ziff
Journal:  Springer Semin Immunopathol       Date:  1989

6.  Intercellular adhesion molecule-1 (ICAM-1) and leukocyte function-associated antigen-1 (LFA-1) expression in human epiretinal membranes.

Authors:  H P Heidenkummer; A Kampik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

7.  Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

Authors:  A A Postigo; R Garcia-Vicuña; F Diaz-Gonzalez; A G Arroyo; M O De Landázuri; G Chi-Rosso; R R Lobb; A Laffon; F Sánchez-Madrid
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

8.  Effects of interferon-gamma on primary cultures of human brain microvessel endothelial cells.

Authors:  H K Huynh; K Dorovini-Zis
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

9.  Lymphocyte migration through cultured endothelial cell monolayers derived from the blood-retinal barrier.

Authors:  J Greenwood; V L Calder
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

10.  Adhesion and penetration properties of human lymphocytes acting on allogeneic vascular endothelial cells.

Authors:  R A Blaheta; M Scholz; N P Hailer; J Bereiter-Hahn; A Encke; B H Markus
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.